PD-L1 expression combined positive score (CPS) influenced overall survival, supporting the importance of immunotherapy and immune targeting in the treatment of R/M HNSCC, and emphasized the importance of the PD-1/PD-L1 pathway in mediating immune evasion in HNSCC. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.